CCL2 and breast cancer: In addition, Ly6C+CCR2+ monocytes that trigger metastasis of mammary tumors were also found to be higher, which is inconsistent with the expression of CCL2, which is known to enhance the establishment of Ly6C+CCR2+ monocyte-assisted lung metastasis (93, 94).